Swiss Windward Bio Gains 7.9% in US Debut After $225 Million IPO and Private Placement

Windward Bio Group AG shares rose 7.9% in their US trading debut after the company raised about $225 million through an initial public offering and private placement, Bloomberg reported.

Source: CoinLive The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.